Blessing Outpatient Behavioral Health Services is offering a new option for depression. As many as 40% of people with depression can find no relief for their condition.
Johnson & Johnson (NYSE:JNJ) is currently addressing shareholder proposals regarding executive compensation and human rights ...
Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...
Johnson & Johnson (NYSE:JNJ) decided to discontinue the Phase 3 VENTURA development program evaluating aticaprant, a kappa ...
Q4 2024 Earnings Call Transcript March 4, 2025 Neuronetics, Inc. misses on earnings expectations. Reported EPS is $-0.33 EPS, expectations were $-0.26. Operator: Good day, and thank you for standing ...
And in for Spravato, we have 63 of our clinics that are ... I think the Q1 guide is $28 million to $30 million. That's a pretty healthy ramp throughout the year that's kind of embedded there ...
In contrast to generic ketamine, Spravato, an intranasal version of ketamine (esketamine), is FDA-approved and therefore is highly regulated. I’m amazed at the differences between the rollout of ...
Riot Games has revealed Waylay as Valorant’s new Agent 28, showcasing additional details about their abilities and more. Here’s everything we know so far about the character. When Valorant ...
We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...
Standing on the shoulders of Johnson & Johnson's Spravato. Upcoming milestones and clinical trials. Psychedelic industry sentiment; RFK Jr influence. Pursuing social anxiety disorder with MDMA.
ETNA, Pa. — A man was hit and killed along Route 28 in Etna after police said he jumped out of a moving car. Allegheny County Police said they were called to the scene at 6:49 a.m. Tuesday for a ...
The reveal date for new Valorant Agent 28 is March 2nd. This has been confirmed by Riot Games’ advertising for the Masters Bangkok Grand Finals. Per Riot Games, fans are encouraged to “Tune in ...